全文获取类型
收费全文 | 102089篇 |
免费 | 7890篇 |
国内免费 | 2832篇 |
专业分类
耳鼻咽喉 | 513篇 |
儿科学 | 1178篇 |
妇产科学 | 898篇 |
基础医学 | 7804篇 |
口腔科学 | 1831篇 |
临床医学 | 9348篇 |
内科学 | 7644篇 |
皮肤病学 | 784篇 |
神经病学 | 3888篇 |
特种医学 | 2577篇 |
外国民族医学 | 22篇 |
外科学 | 16888篇 |
综合类 | 18834篇 |
现状与发展 | 4篇 |
一般理论 | 4篇 |
预防医学 | 9121篇 |
眼科学 | 1218篇 |
药学 | 11165篇 |
286篇 | |
中国医学 | 12812篇 |
肿瘤学 | 5992篇 |
出版年
2024年 | 186篇 |
2023年 | 1556篇 |
2022年 | 2540篇 |
2021年 | 4239篇 |
2020年 | 3903篇 |
2019年 | 3781篇 |
2018年 | 3297篇 |
2017年 | 3441篇 |
2016年 | 3317篇 |
2015年 | 3414篇 |
2014年 | 6743篇 |
2013年 | 6487篇 |
2012年 | 6355篇 |
2011年 | 7248篇 |
2010年 | 6251篇 |
2009年 | 4962篇 |
2008年 | 4888篇 |
2007年 | 5288篇 |
2006年 | 4574篇 |
2005年 | 3902篇 |
2004年 | 3288篇 |
2003年 | 2812篇 |
2002年 | 2158篇 |
2001年 | 1903篇 |
2000年 | 1482篇 |
1999年 | 1299篇 |
1998年 | 1160篇 |
1997年 | 1022篇 |
1996年 | 759篇 |
1995年 | 886篇 |
1994年 | 815篇 |
1993年 | 689篇 |
1992年 | 618篇 |
1991年 | 552篇 |
1990年 | 474篇 |
1989年 | 461篇 |
1988年 | 470篇 |
1987年 | 406篇 |
1986年 | 391篇 |
1985年 | 651篇 |
1984年 | 609篇 |
1983年 | 459篇 |
1982年 | 523篇 |
1981年 | 447篇 |
1980年 | 443篇 |
1979年 | 370篇 |
1978年 | 322篇 |
1977年 | 273篇 |
1976年 | 224篇 |
1975年 | 126篇 |
排序方式: 共有10000条查询结果,搜索用时 234 毫秒
1.
《Cancer radiothérapie》2022,26(4):611-615
In order to provide more convenient irradiation regimens for patient comfort, radiation facility organization and health expenses, new hypofractionated protocols have been evaluated. Moderately (dose/fraction: 2.3 to 3 Gy), then ultra (dose/fraction: 5.2 to 6.1 Gy) hypofractionated irradiations were first validated. The current question is: is it possible to go forward using extreme hypofractionated regimens (EHR) based on 1 to 3 fractions. Different irradiation techniques are under investigation. However, brachytherapy remains the smartest way to deliver a high dose in a small volume. We report prospective and retrospective study results which evaluated EHR for breast and prostate brachytherapy. While oncological outcome and toxicity profile appear extremely encouraging for low-risk breast cancer after a 1 to 4 fractions (6.25 to 20 Gy/fraction), the use of a single fraction of 19 to 23 Gy appears debatable for prostate cancer. Brachytherapy represents an emblematic example of EHR but longer follow-up and more mature results are awaited in order to specify the right indications and refine the EQD2 calculation method including new biological and technical factors. 相似文献
2.
熊磊教授以理脾为本,将治痰贯穿始终。根据小儿脾常不足、肾常虚、肝常有余的生理特点,癫痫发作期治疗主以涤痰开窍,辅以理气健脾,同时配合活血化瘀通窍与平肝息风潜阳。主要选方为柴芍温胆汤、天麻钩藤饮、桃红四物汤加减;缓解期则以补肾养肝为主,兼以健脾化痰,主要选方为杞菊地黄丸合定痫丸加减,取得较好临床疗效。 相似文献
3.
以“七麦数据”网站收录的中医移动医疗App作为研究对象,采用网络调查法和文献分析法,根据“七麦数据”对移动医疗App的分类,结合中医移动医疗App的信息服务内容和特点,将筛选出的中医移动医疗App划分为医疗健康类、中医养生类、知识传播类、全面综合类,并根据“七麦数据”网站中对各类中医移动医疗App的打分及累计下载量筛选出最具代表性的12款中医移动医疗App,从全面性、人性化、安全性、实用性4个一级指标和40个二级指标对其信息服务现状进行评价,指出当前中医移动医疗App信息服务存在的问题并提出建议。 相似文献
4.
5.
《Orthopaedics and Trauma》2022,36(6):304-310
Congenital vertical talus (CVT) is a rare foot deformity that presents with a rigid flat foot at birth. CVT can present as an isolated abnormality in the newborn, however in at least 50% of cases in association with other conditions. Full neuro-axial imaging is essential to detect any associated neurologic problems. Radiographs of the foot, including forced plantar and dorsiflexion laterals, are diagnostic. Gold standard modern treatment uses the Dobbs method of serial manipulation and casting with minimally-invasive stabilization of the talonavicular joint and Achilles tendon tenotomy. 相似文献
6.
7.
8.
9.
10.
《Journal of vascular and interventional radiology : JVIR》2022,33(4):359-367.e8
PurposeTo review and to compare indirectly the outcomes of minimally invasive therapies for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.Materials and MethodsA literature search via Medline and Cochrane Central databases was completed for randomized control studies published between January 2000 to April 2020 for the following therapies: Rezum, Urolift, Aquablation, and prostatic artery embolization (PAE). Data on the following variables were included: International prostate symptom score (IPSS), maximum urinary flow rate, quality of life, and postvoid residual (PVR). Standard mean differences between treatments were compared through a meta-analysis using transurethral resection of the prostate (TURP) to assess differences in treatment effect.ResultsThere was no significant difference in outcomes between therapies for IPSS at the 3, 6, and 12-month follow ups. Although outcomes for Rezum were only available out to 3 months, there were no consistently significant differences in outcomes when comparing Aquablation versus PAE versus Rezum. TURP PVR was significantly better than Urolift at 3, 6, and 12 months. No significant differences in minor or major adverse events were noted.ConclusionAlthough significant differences in outcomes were limited, Aquablation and PAE were the most durable at 12 months. PAE has been well studied on multiple randomized control trials with minimal adverse events while Aquablation has limited high quality data and has been associated with bleeding-related complications. 相似文献